rac-6-{[2-Aminocyclohexyl]amino}-2-(3-methylanilino)pyridine-3-carboxamide

ID: ALA4553573

PubChem CID: 9949798

Max Phase: Preclinical

Molecular Formula: C19H25N5O

Molecular Weight: 339.44

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Cc1cccc(Nc2nc(NC3CCCCC3N)ccc2C(N)=O)c1

Standard InChI:  InChI=1S/C19H25N5O/c1-12-5-4-6-13(11-12)22-19-14(18(21)25)9-10-17(24-19)23-16-8-3-2-7-15(16)20/h4-6,9-11,15-16H,2-3,7-8,20H2,1H3,(H2,21,25)(H2,22,23,24)

Standard InChI Key:  GLYDOFDMRWDEDQ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
    3.9277   -2.6662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9266   -3.4857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6346   -3.8947    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3443   -3.4852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3414   -2.6626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6328   -2.2573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2199   -2.2577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2197   -1.4405    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5123   -2.6665    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2185   -3.8937    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2179   -4.7109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5097   -5.1174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5087   -5.9338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2167   -6.3438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9270   -5.9314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9245   -5.1163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0526   -3.8927    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0539   -4.7099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3439   -5.1148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3432   -5.9284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0497   -6.3397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7586   -5.9312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7609   -5.1114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4678   -4.7013    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8005   -6.3415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  7  8  1  0
  7  9  2  0
  2 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  4 17  1  0
 18 17  1  0
 18 19  1  0
 18 23  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 13 25  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4553573

   6-[(2-Aminocyclohexyl)amino]-2-(3-methylanilino)pyridine-3-carboxamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 339.44

Molecular Weight (Monoisotopic): 339.2059

AlogP: 2.91

#Rotatable Bonds: 5

Polar Surface Area: 106.06

Molecular Species: BASE

HBA: 5

HBD: 4

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 6

#RO5 Violations (Lipinski): 1

CX Acidic pKa: ┄

CX Basic pKa: 9.92

CX LogP: 4.14

CX LogD: 1.74

Aromatic Rings: 2

Heavy Atoms: 25

QED Weighted: 0.67

Np Likeness Score: -0.95

References

1. Taniguchi T, Inagaki H, Baba D, Yasumatsu I, Toyota A, Kaneta Y, Kiga M, Iimura S, Odagiri T, Shibata Y, Ueda K, Seo M, Shimizu H, Imaoka T, Nakayama K..  (2019)  Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity.,  10  (5): [PMID:31097992] [10.1021/acsmedchemlett.8b00631]

Source

Source(1):

• Scientific Literature